Simvastatin enhances hippocampal long-term potentiation in C57BL/6 mice.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Neuroscience

• Publication date

  2010-03-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neuroscience.2009.12.062PMID 20040368PMCID PMC2824052
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biphasic requirement for geranylgeraniol in hippocampal long-term potentiation

  2008cited by this paper
• Simvastatin-Mediated Upregulation of VEGF and BDNF, Activation of the PI3K/Akt Pathway, and Increase of Neurogenesis Are Associated with Therapeutic Improvement after Traumatic Brain Injury

  2008cited by this paper
• A Pivotal Role for Interleukin-4 in Atorvastatin-associated Neuroprotection in Rat Brain*

  2008cited by this paper
• The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-beta1-42 in the rat hippocampus in vivo.

  2007cited by this paper
• Pravastatin induces rat aortic endothelial cell proliferation and migration via activation of PI3K/Akt/mTOR/p70 S6 kinase signaling.

  2007cited by this paper
• Age‐dependent requirement of AKAP150‐anchored PKA and GluR2‐lacking AMPA receptors in LTP

  2007influential reference
• Statins Increase Neurogenesis in the Dentate Gyrus, Reduce Delayed Neuronal Death in the Hippocampal CA3 Region, and Improve Spatial Learning in Rat after Traumatic Brain Injury

  2007influential reference
• Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease

  2007cited by this paper
• Simvastatin enhances learning and memory independent of amyloid load in mice

  2006influential reference
• Brain cholesterol turnover required for geranylgeraniol production and learning in mice.

  2006influential reference
• Estradiol-Induced Increase in the Magnitude of Long-Term Potentiation Is Prevented by Blocking NR2B-Containing Receptors

  2006cited by this paper
• The 3‐hydroxy‐3‐methylglutaryl co‐enzyme A reductase inhibitor pravastatin enhances neurite outgrowth in hippocampal neurons

  2006cited by this paper
• Neurobiology of Disease 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors Attenuate-Amyloid-Induced Microglial Inflammatory Responses

  2005cited by this paper
• 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors attenuate beta-amyloid-induced microglial inflammatory responses.

  2005cited by this paper
• Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

  2005cited by this paper
• Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: a model of Down syndrome.

  2005cited by this paper
• Neuroprotective effects of atorvastatin against glutamate‐induced excitotoxicity in primary cortical neurones

  2005cited by this paper
• Statin treatment and a disease-specific pattern of β-amyloid peptides in Alzheimer’s disease

  2005cited by this paper
• Role of AMPA receptor desensitization and the side effects of a DMSO vehicle on reticulospinal EPSPs and locomotor activity.

  2005cited by this paper
• Estrogen-Induced Increase in the Magnitude of Long-Term Potentiation Occurs Only When the Ratio of NMDA Transmission to AMPA Transmission Is Increased

  2005influential reference
• LTP and LTD: an embarrassment of riches.

  2004cited by this paper
• The discovery and development of HMG-CoA reductase inhibitors. 1992.

  2004cited by this paper
• Plasma levels of beta-amyloid(1-40), beta-amyloid(1-42), and total beta-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins.

  2004cited by this paper
• Plasma Levels of β-Amyloid(1-40), β-Amyloid(1-42), and Total β-Amyloid Remain Unaffected in Adult Patients With Hypercholesterolemia After Treatment With Statins

  2004cited by this paper
• Prophylactic but Not Delayed Administration of Simvastatin Protects Against Long-Lasting Cognitive and Morphological Consequences of Neonatal Hypoxic-Ischemic Brain Injury, Reduces Interleukin-1&bgr; and Tumor Necrosis Factor-&agr; mRNA Induction, and Does Not Affect Endothelial Nitric Oxide Synthas

  2003cited by this paper
• Prevention of stroke and dementia with statins: Effects beyond lipid lowering.

  2003cited by this paper
• Comparing HMG‐CoA reductase inhibitors

  2003cited by this paper
• Phosphatidylinositol 3-Kinase Regulates the Induction of Long-Term Potentiation through Extracellular Signal-Related Kinase-Independent Mechanisms

  2003influential reference
• 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Protect Cortical Neurons from Excitotoxicity

  2003influential reference
• HMG-CoA reductase inhibitors promote cholesterol-dependent Akt/PKB translocation to membrane domains in endothelial cells.

  2003cited by this paper
• Long-term potentiation: outstanding questions and attempted synthesis.

  2003cited by this paper
• PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity

  2003cited by this paper
• Treatment with Simvastatin in Patients with Alzheimer’s Disease Lowers Both α- and β-Cleaved Amyloid Precursor Protein

  2003cited by this paper
• Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke

  2003influential reference
• Treatment with simvastatin in patients with Alzheimer's disease lowers both alpha- and beta-cleaved amyloid precursor protein.

  2003cited by this paper
• A developmental switch in the signaling cascades for LTP induction

  2003cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Molecular dissection of hippocampal theta-burst pairing potentiation

  2002cited by this paper
• Isoprenoids as mediators of the biological effects of statins.

  2002cited by this paper
• Pharmacological concentrations of the HMG-CoA reductase inhibitor lovastatin decrease the formation of the Alzheimer beta-amyloid peptide in vitro and in patients.

  2002cited by this paper
• Phosphatidylinositol 3-Kinase Is Required for the Expression But Not for the Induction or the Maintenance of Long-Term Potentiation in the Hippocampal CA1 Region

  2002cited by this paper
• Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide

  2002cited by this paper
• Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26‐week randomized, placebo‐controlled, double‐blind trial

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

  2002cited by this paper
• ERRATA

  2001cited by this paper
• [Statins and the risk of dementia].

  2001cited by this paper
• Dimethyl sulfoxide suppresses NMDA- and AMPA-induced ion currents and calcium influx and protects against excitotoxic death in hippocampal neurons.

  2001cited by this paper
• Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

  2000cited by this paper
• Reduced long-term potentiation in hippocampal slices prepared using sucrose-based artificial cerebrospinal fluid.

  2000cited by this paper
• The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.

  2000cited by this paper
• Statins and the risk of dementia.

  2000cited by this paper
• An Embarrassment of Riches

  1992cited by this paper
• The discovery and development of HMG-CoA reductase inhibitors.

  1992cited by this paper
• A receptor-mediated pathway for cholesterol homeostasis.

  1986cited by this paper
• THE EFFECT OF DIMETHYL SULFOXIDE ON THE NEURONAL EXCITABILITY AND CHOLINERGIC TRANSMISSION IN APLYSIA GANGLION CELLS *

  1975cited by this paper

• Lipids shape brain function through ion channel and receptor modulations: physiological mechanisms and clinical perspectives.

  2024cites this paper
• Association Between Statin Use and Dementia, and Related Mechanisms: A Bibliometric Analysis from 2007 to 2023

  2024cites this paper
• Simvastatin ameliorates synaptic plasticity impairment in chronic mild stress-induced depressed mice by modulating hippocampal NMDA receptor

  2023cites this paper
• Role of rafts in neurological disorders.

  2023cites this paper
• Complementary Medications (Statins, Nicergoline, Naftidrofuryl) in Dementia

  2021cites this paper
• Contribution of Membrane Lipids to Postsynaptic Protein Organization

  2021influential citation
• Role of rafts in neurological disorders.

  2021cites this paper
• Effects of 7,8-Dihydroxyflavone on Lipid Isoprenoid and Rho Protein Levels in Brains of Aged C57BL/6 Mice

  2020cites this paper
• Simvastatin impairs hippocampal synaptic plasticity and cognitive function in mice

  2020cites this paper
• Farnesyl Transferase Inhibitor Lonafarnib Enhances α7nAChR Expression Through Inhibiting DNA Methylation of CHRNA7 and Increases α7nAChR Membrane Trafficking

  2020influential citation
• Biocatalyzed Synthesis of Statins: A Sustainable Strategy for the Preparation of Valuable Drugs

  2019cites this paper
• Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer’s disease

  2018cites this paper
• Simvastatin Enhances Activity and Trafficking of α7 Nicotinic Acetylcholine Receptor in Hippocampal Neurons Through PKC and CaMKII Signaling Pathways

  2018cites this paper
• Lovastatin, not Simvastatin, Corrects Core Phenotypes in the Fragile X Mouse Model

  2018cites this paper
• Influence of fisetin combined with hesperidin on chronic mild hyperhomocysteinemia induced cognitive dysfunction and oxidative stress in wistar rats

  2018cites this paper
• Overview the effect of statin therapy on dementia risk, cognitive changes and its pathologic change: a systematic review and meta-analysis.

  2018cites this paper
• Ras inhibitor S‐trans, trans‐farnesylthiosalicylic acid enhances spatial memory and hippocampal long‐term potentiation via up‐regulation of NMDA receptor

  2018cites this paper
• Combined Effects of Donepezil and Lovastatin on Cognition Deficit Induced by Bilateral Lesion of the Nucl. Basalis Magnocellularis in a Rat Model of Alzheimer’s Disease

  2018cites this paper
• Incorporating Topic Assignment Constraint and Topic Correlation Limitation into Clinical Goal Discovering for Clinical Pathway Mining

  2017cites this paper
• Exploring the biochemistry of the prenylome and its role in disease through proteomics: progress and potential

  2017cites this paper
• Atorvastatin Decreases HBx-Induced Phospho-Akt in Hepatocytes via P2X Receptors

  2017cites this paper
• The role of Simvastatin in preventing diet-induced cognitive decline

  2017cites this paper
• 2 Regenerative Medicine for Cerebral Infarction

  2017cites this paper
• Potential Treatments for Alzheimer’s Disease

  2017cites this paper
• Effects of fisetin on hyperhomocysteinemia-induced experimental endothelial dysfunction and vascular dementia.

  2017cites this paper
• Atorvastatin in improvement of cognitive impairments caused by amyloid β in mice: involvement of inflammatory reaction

  2016cites this paper
• Hesperidin, a citrus flavonoid, protects against l-methionine-induced hyperhomocysteinemia by abrogation of oxidative stress, endothelial dysfunction and neurotoxicity in Wistar rats

  2016cites this paper
• Simvastatin enhances NMDA receptor GluN2B expression and phosphorylation of GluN2B and GluN2A through increased histone acetylation and Src signaling in hippocampal CA1 neurons.

  2016cites this paper
• Neurovascular and Cognitive failure in Alzheimer’s Disease: Benefits of Cardiovascular Therapy

  2016cites this paper
• NGF but not BDNF overexpression protects hippocampal LTP from beta-amyloid-induced impairment.

  2015cites this paper
• Effects of alpha-tocopherol associated with lovastatin on brain tissue and memory function in SHRSPs.

  2015cites this paper
• Simvastatin Enhances Spatial Memory and Long-Term Potentiation in Hippocampal CA1 via Upregulation of α7 Nicotinic Acetylcholine Receptor

  2015cites this paper
• Statins enhance cognitive performance in object location test in albino Swiss mice: involvement of beta-adrenoceptors.

  2015cites this paper
• Simvastatin prevents β-amyloid(25-35)-impaired neurogenesis in hippocampal dentate gyrus through α7nAChR-dependent cascading PI3K-Akt and increasing BDNF via reduction of farnesyl pyrophosphate.

  2015cites this paper
• Simvastatin increases excitability in the hippocampus via a PI3 kinase-dependent mechanism.

  2015cites this paper
• LTP-triggered cholesterol redistribution activates Cdc42 and drives AMPA receptor synaptic delivery

  2015cites this paper
• LTP-triggered cholesterol redistribution activates Cdc42 and drives AMPA receptor synaptic delivery

  2015cites this paper
• LTP-triggered cholesterol redistribution activates Cdc 42 and drives AMPA receptor synaptic delivery

  2015cites this paper
• JCB_201407122 1..16

  2015cites this paper
• Simvastatin Treatment Preserves Synaptic Plasticity in AβPPswe/PS1dE9 Mice

  2014cites this paper
• An acetylcholinesterase inhibitor, eserine, induces long-term depression at CA3-CA1 synapses in the hippocampus of adult rats.

  2014cites this paper
• Simvastatin Exerts Antiamnesic Effect in Aβ25‐35‐Injected Mice

  2014cites this paper
• Effects of HMG-CoA reductase inhibitors on learning and memory in the guinea pig.

  2014cites this paper
• Atorvastatin prevents ATP-driven invasiveness via P2X7 and EHBP1 signaling in PTEN-expressing prostate cancer cells.

  2014cites this paper
• Simvastatin Treatment Enhances NMDAR-Mediated Synaptic Transmission by Upregulating the Surface Distribution of the GluN2B Subunit

  2014cites this paper
• Protein Prenylation and Synaptic Plasticity: Implications for Alzheimer’s Disease

  2014cites this paper
• Impaired geranylgeranyltransferase‐I regulation reduces membrane‐associated Rho protein levels in aged mouse brain

  2014cites this paper
• Cholesterol homeostasis failure in the brain: implications for synaptic dysfunction and cognitive decline.

  2014cites this paper
• Lipid rafts, synaptic transmission and plasticity: impact in age-related neurodegenerative diseases.

  2013cites this paper
• Farnesyltransferase Haplodeficiency Reduces Neuropathology and Rescues Cognitive Function in a Mouse Model of Alzheimer Disease*

  2013cites this paper
• Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes

  2013cites this paper
• Initiation Of Statin Therapy - Lack Of Effect On MR Spectroscopy And Cerebral Perfusion

  2013cites this paper
• Adjuvant effects of classical music on simvastatin induced reduction of anxiety but not object recognition memory in rats

  2013cites this paper
• Chronic Pravastatin but Not Atorvastatin Treatment Impairs Cognitive Function in Two Rodent Models of Learning and Memory

  2013cites this paper
• The effect of statins on performance in the Morris water maze in guinea pig.

  2012cites this paper
• Cholesterol loss during glutamate‐mediated excitotoxicity

  2012cites this paper
• Age-Dependent Rescue by Simvastatin of Alzheimer's Disease Cerebrovascular and Memory Deficits

  2012cites this paper
• Isoprenoids and Related Pharmacological Interventions: Potential Application in Alzheimer’s Disease

  2012influential citation
• Prenylation of Rho G-Proteins: a Novel Mechanism Regulating Gene Expression and Protein Stability in Human Trabecular Meshwork Cells

  2012cites this paper
• Simvastatin-mediated enhancement of long-term potentiation is driven by farnesyl-pyrophosphate depletion and inhibition of farnesylation.

  2012influential citation
• Simvastatin improves learning and memory in control but not in olfactory bulbectomized rats

  2011cites this paper
• Regenerative Medicine for Cerebral Infarction

  2011cites this paper
• Atorvastatin improved scopolamine-induced impairment in memory acquisition in mice: involvement of nitric oxide.

  2011cites this paper
• Nitric oxide involvement in consolidation, but not retrieval phase of cognitive performance enhanced by atorvastatin in mice.

  2011cites this paper
• The flavonoid baicalein promotes NMDA receptor‐dependent long‐term potentiation and enhances memory

  2011cites this paper
• Potential Therapeutic Strategies for Neurodegenerative Diseases

  2010cites this paper
• Pitavastatin and 4'-hydroxy-3'-methoxyacetophenone (HMAP) reduce cognitive dysfunction in vascular dementia during experimental diabetes.

  2010cites this paper
• Synergistic benefits of erythropoietin and simvastatin after traumatic brain injury.

  2010cites this paper
• Biodiscovery of chemo preventatives of Alzheimer’s disease using yeast

  2010cites this paper